February 5, 2016 (LocalOrg) - Agree or disagree with her methods, Liz Parrish and her company, Bioviva are taking gene therapy into their own hands in an attempt to circumvent the corrupt pharmaceutical monopolies, their representatives in the media and government, and shift the paradigm toward a more decentralized means of research and development.
